Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Macon MB, Villanueva LR, Tatum-Gibbs K, Zehr RD, Strynar MJ, Stanko JP, White SS, Helfant L, Fenton SE.

Toxicol Sci. 2011 Jul;122(1):134-45. doi: 10.1093/toxsci/kfr076. Epub 2011 Apr 11.

PMID:
21482639
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.

White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C, Fenton SE.

Toxicol Sci. 2007 Mar;96(1):133-44. Epub 2006 Nov 28.

PMID:
17132714
[PubMed - indexed for MEDLINE]
Free Article
3.

Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice.

White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE.

Environ Health Perspect. 2011 Aug;119(8):1070-6. doi: 10.1289/ehp.1002741. Epub 2011 Apr 18.

PMID:
21501981
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups.

Fenton SE, Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Hines EP, White SS, Lindstrom AB, Strynar MJ, Petropoulou SS.

Reprod Toxicol. 2009 Jun;27(3-4):365-72. doi: 10.1016/j.reprotox.2009.02.012. Epub 2009 Mar 9.

PMID:
19429407
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures.

Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, Thibodeaux J, Das KP, White SS, Lau CS, Abbott BD.

Toxicol Sci. 2007 Feb;95(2):462-73. Epub 2006 Nov 10.

PMID:
17098816
[PubMed - indexed for MEDLINE]
Free Article
6.

Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol.

Henderson WM, Smith MA.

Toxicol Sci. 2007 Feb;95(2):452-61. Epub 2006 Nov 8.

PMID:
17093205
[PubMed - indexed for MEDLINE]
Free Article
7.

Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ.

Toxicol Sci. 2006 Apr;90(2):510-8. Epub 2006 Jan 16.

PMID:
16415327
[PubMed - indexed for MEDLINE]
Free Article
8.

Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.

Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE.

Mol Cell Endocrinol. 2009 May 25;304(1-2):97-105. doi: 10.1016/j.mce.2009.02.021. Epub 2009 Mar 9.

PMID:
19433254
[PubMed - indexed for MEDLINE]
9.

Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures.

White SS, Kato K, Jia LT, Basden BJ, Calafat AM, Hines EP, Stanko JP, Wolf CJ, Abbott BD, Fenton SE.

Reprod Toxicol. 2009 Jun;27(3-4):289-98. doi: 10.1016/j.reprotox.2008.11.054. Epub 2008 Nov 27.

PMID:
19095057
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effects of perfluorooctanoic acid (PFOA) exposure to pregnant mice on reproduction.

Yahia D, El-Nasser MA, Abedel-Latif M, Tsukuba C, Yoshida M, Sato I, Tsuda S.

J Toxicol Sci. 2010 Aug;35(4):527-33.

PMID:
20686339
[PubMed - indexed for MEDLINE]
Free Article
11.

Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA?

Hu Q, Strynar MJ, DeWitt JC.

J Immunotoxicol. 2010 Oct-Dec;7(4):344-9. doi: 10.3109/1547691X.2010.520045. Epub 2010 Oct 18.

PMID:
20954796
[PubMed - indexed for MEDLINE]
12.

Does developmental exposure to perflurooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders?

Hu Q, Franklin JN, Bryan I, Morris E, Wood A, DeWitt JC.

Neurotoxicology. 2012 Dec;33(6):1491-8. doi: 10.1016/j.neuro.2012.10.016. Epub 2012 Nov 5.

PMID:
23137609
[PubMed - indexed for MEDLINE]
13.
14.

Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.

Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Fenton SE, Lindstrom AB, Strynar MJ.

Reprod Toxicol. 2009 Jun;27(3-4):360-4. doi: 10.1016/j.reprotox.2008.10.006. Epub 2008 Nov 6.

PMID:
19028561
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice.

Ngo HT, Hetland RB, Sabaredzovic A, Haug LS, Steffensen IL.

Environ Res. 2014 Jul;132:251-63. doi: 10.1016/j.envres.2014.03.033. Epub 2014 May 13.

PMID:
24834819
[PubMed - indexed for MEDLINE]
16.

Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice.

Zhao Y, Tan YS, Strynar MJ, Perez G, Haslam SZ, Yang C.

Reprod Toxicol. 2012 Jul;33(4):563-76. doi: 10.1016/j.reprotox.2012.02.004. Epub 2012 Mar 5.

PMID:
22414604
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.

Abbott BD, Wolf CJ, Das KP, Zehr RD, Schmid JE, Lindstrom AB, Strynar MJ, Lau C.

Reprod Toxicol. 2009 Jun;27(3-4):258-65. doi: 10.1016/j.reprotox.2008.05.061. Epub 2008 May 24.

PMID:
18595657
[PubMed - indexed for MEDLINE]
18.

Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA.

Toxicol Sci. 2003 Aug;74(2):382-92. Epub 2003 May 28.

PMID:
12773772
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues.

Abbott BD, Wood CR, Watkins AM, Tatum-Gibbs K, Das KP, Lau C.

Reprod Toxicol. 2012 Jul;33(4):491-505. doi: 10.1016/j.reprotox.2011.11.005. Epub 2011 Dec 1.

PMID:
22154759
[PubMed - indexed for MEDLINE]
20.

Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.

Dixon D, Reed CE, Moore AB, Gibbs-Flournoy EA, Hines EP, Wallace EA, Stanko JP, Lu Y, Jefferson WN, Newbold RR, Fenton SE.

Reprod Toxicol. 2012 Jul;33(4):506-12. doi: 10.1016/j.reprotox.2011.10.011. Epub 2011 Nov 28.

PMID:
22146484
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk